ChEM-H-funded projects

Young Stanford biotech entrepreneurs are using their $50,000 award to work towards a cure for a rare muscular dystrophy

Stanford undergraduates win $50K through a program designed to teach undergraduates about biotech entrepreneurship

The grants will allow Stanford researchers to collaborate with the Nucleus, a collection of labs designed to supercharge basic and translational science at Stanford.

The winning team, Myoterra Biosciences, is working to develop a new therapy for FSHD, a rare genetic disease that affects nearly one million people worldwide.

The Sarafan ChEM-H grant will support the undergrad entrepreneurs as they work to develop treatment for a rare form of cancer called uveal melanoma.

With funding and support from ChEM-H, a team of undergrads is bringing their idea to kickstart the body’s immune system closer to reality.

By establishing an optimal method for extracting viral RNA from feces, the researchers hope to make coronavirus fecal and wastewater studies more accurate and comparable.

A ChEM-H-funded study finds that a repurposed drug could be a solution to curbing the spread of the coronavirus.

Stanford ChEM-H has named 11 incoming students O’Leary-Thiry Graduate Fellows and two current students Stanford Interdisciplinary Graduate Fellows to pursue research at the CBI.

Jennifer Cao and Cole Dovey met at the Stanford ChEM-H Postdoc Retreat and discovered that they shared an interest in cell death pathways.

Students in the Stanford ChEM-H Undergraduate Entrepreneurship Program have been awarded a grant to pursue their idea for a new biotechnology company.